BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34350376)

  • 21. Out-of-Pocket Costs for Advanced Imaging Across the US Private Insurance Marketplace.
    Rosenkrantz AB; Sadigh G; Carlos RC; Silva E; Duszak R
    J Am Coll Radiol; 2018 Apr; 15(4):607-614.e1. PubMed ID: 29477290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Out-of-Pocket and Total Costs for Common Hand Procedures From 2008 to 2016: A Nationwide Claims Database Analysis.
    Michaud JB; Zhuang T; Shapiro LM; Cohen SA; Kamal RN
    J Hand Surg Am; 2022 Nov; 47(11):1057-1067. PubMed ID: 35985865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmaceutical policies: effects of cap and co-payment on rational drug use.
    Austvoll-Dahlgren A; Aaserud M; Vist G; Ramsay C; Oxman AD; Sturm H; Kösters JP; Vernby A
    Cochrane Database Syst Rev; 2008 Jan; (1):CD007017. PubMed ID: 18254125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rising Prices of Targeted Oral Anticancer Medications and Associated Financial Burden on Medicare Beneficiaries.
    Shih YT; Xu Y; Liu L; Smieliauskas F
    J Clin Oncol; 2017 Aug; 35(22):2482-2489. PubMed ID: 28471711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Out-of-Pocket Spending for Asthma-Related Care Among Commercially Insured Patients, 2004-2016.
    Sinaiko AD; Gaye M; Wu AC; Bambury E; Zhang F; Xu X; Wharam JF; Galbraith AA
    J Allergy Clin Immunol Pract; 2021 Dec; 9(12):4324-4331.e7. PubMed ID: 34481128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in Total and Out-of-pocket Payments for Noninsulin Glucose-Lowering Drugs Among U.S. Adults With Large-Employer Private Health Insurance From 2005 to 2018.
    Shao H; Laxy M; Benoit SR; Cheng YJ; Gregg EW; Zhang P
    Diabetes Care; 2021 Apr; 44(4):925-934. PubMed ID: 33563653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient out-of-pocket spending in cranial neurosurgery: single-institution analysis of 6569 consecutive cases and literature review.
    Yoon S; Mooney MA; Bohl MA; Sheehy JP; Nakaji P; Little AS; Lawton MT
    Neurosurg Focus; 2018 May; 44(5):E6. PubMed ID: 29712524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Branded Prescription Drug Rebate Size and Patient Out-of-Pocket Costs in a Nationally Representative Sample, 2007-2018.
    Yeung K; Dusetzina SB; Basu A
    JAMA Netw Open; 2021 Jun; 4(6):e2113393. PubMed ID: 34125219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High Deductibles are Associated With Severe Disease, Catastrophic Out-of-Pocket Payments for Emergency Surgical Conditions.
    Scott JW; Neiman PU; Scott KW; Ibrahim AM; Fan Z; Fendrick AM; Dimick JB
    Ann Surg; 2023 Oct; 278(4):e667-e674. PubMed ID: 36762565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer History, Health Insurance Coverage, and Cost-Related Medication Nonadherence and Medication Cost-Coping Strategies in the United States.
    Zhao J; Zheng Z; Han X; Davidoff AJ; Banegas MP; Rai A; Jemal A; Yabroff KR
    Value Health; 2019 Jul; 22(7):762-767. PubMed ID: 31277821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative analysis of caesarean delivery among out-of-pocket and health insurance clients in Ilorin, Nigeria.
    Adeniran AS; Aun II; Fawole AA; Aboyeji AP
    Niger Postgrad Med J; 2020; 27(2):108-114. PubMed ID: 32295941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adoption of Cost Effectiveness-Driven Value-Based Formularies in Private Health Insurance from 2010 to 2013.
    Brouwer ED; Basu A; Yeung K
    Pharmacoeconomics; 2019 Oct; 37(10):1287-1300. PubMed ID: 31270747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of High-Deductible Health Plans on Breast Reconstruction: Considerations for Financial Toxicity.
    Shamsunder MG; Sheckter CC; Sheinin A; Rubin D; Parikh RP; Rose J; Momoh AO; Offodile AC; Matros E
    Plast Reconstr Surg; 2023 Feb; 151(2):245-253. PubMed ID: 36696302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Out-of-pocket financial burden for low-income families with children: socioeconomic disparities and effects of insurance.
    Galbraith AA; Wong ST; Kim SE; Newacheck PW
    Health Serv Res; 2005 Dec; 40(6 Pt 1):1722-36. PubMed ID: 16336545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compliance with biologic therapies for rheumatoid arthritis: do patient out-of-pocket payments matter?
    Curkendall S; Patel V; Gleeson M; Campbell RS; Zagari M; Dubois R
    Arthritis Rheum; 2008 Oct; 59(10):1519-26. PubMed ID: 18821651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical insurance payment schemes and patient medical expenses: a cross-sectional study of lung cancer patients in urban China.
    Hu H; Zhao L; Yong Y; Nicholas S; Maitland E; Zhao W; Yan H; Ma Y; Shi X
    BMC Health Serv Res; 2023 Jan; 23(1):89. PubMed ID: 36703175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Healthcare expenditures for privately insured people with cystic fibrosis.
    Ouyang L; Grosse SD; Amendah DD; Schechter MS
    Pediatr Pulmonol; 2009 Oct; 44(10):989-96. PubMed ID: 19768806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Out-of-Pocket and Health Care Spending Changes for Patients Using Orally Administered Anticancer Therapy After Adoption of State Parity Laws.
    Dusetzina SB; Huskamp HA; Winn AN; Basch E; Keating NL
    JAMA Oncol; 2018 Jun; 4(6):e173598. PubMed ID: 29121177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Out-of-pocket health care expenditure burden for Medicare beneficiaries with cancer.
    Davidoff AJ; Erten M; Shaffer T; Shoemaker JS; Zuckerman IH; Pandya N; Tai MH; Ke X; Stuart B
    Cancer; 2013 Mar; 119(6):1257-65. PubMed ID: 23225522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accuracy of Physician Estimates of Out-of-Pocket Costs for Medication Filling.
    Sloan CE; Millo L; Gutterman S; Ubel PA
    JAMA Netw Open; 2021 Nov; 4(11):e2133188. PubMed ID: 34739059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.